This European consortium aims to set up initiatives to prevent Alzheimer’s disease and to better understand the biological mechanisms of this disease. Initially, a register of 24,000 subjects is to be established from which a cohort of 2,000 people with a pre-Alzheimer’s disease stage will be established and who will be proposed to participate in therapeutic trials with the new Molecules under development.

EPAD has just released on 10 March an introductory English video of 3.30 minutes to watch on